RAB7L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.854500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.087000E-01
Normal-vs-Stage2
9.312300E-02
Normal-vs-Stage3
8.144500E-02
Normal-vs-Stage4
5.724800E-01
Stage1-vs-Stage2
1.816650E-01
Stage1-vs-Stage3
6.144100E-02
Stage1-vs-Stage4
9.914800E-01
Stage2-vs-Stage3
1.216790E-01
Stage2-vs-Stage4
2.730400E-01
Stage3-vs-Stage4
3.183800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.437800E-02
Normal-vs-AfricanAmerican
3.440600E-01
Normal-vs-Asian
3.288800E-01
Caucasian-vs-AfricanAmerican
4.524400E-01
Caucasian-vs-Asian
9.991600E-01
AfricanAmerican-vs-Asian
3.335200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.251950E-01
Normal-vs-Female
6.308400E-02
Male-vs-Female
8.755800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.214600E-01
Normal-vs-Age(41-60Yrs)
7.207700E-02
Normal-vs-Age(61-80Yrs)
1.147410E-01
Normal-vs-Age(81-100Yrs)
3.453400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.487400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.714400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.576840E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.168000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.699000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.329000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.573700E-02
Normal-vs-Daily Drinker
3.861300E-03
Normal-vs-Weekly Drinker
3.740600E-01
Normal-vs-Occasional Drinker
1.602400E-01
Normal-vs-Social Drinker
2.280800E-01
Non Drinker-vs-Daily Drinker
7.603500E-02
Non Drinker-vs-Weekly Drinker
3.550400E-01
Non Drinker-vs-Occasional Drinker
5.233000E-01
Non Drinker-vs-Social Drinker
5.296400E-01
Daily Drinker-vs-Weekly Drinker
6.064100E-02
Daily Drinker-vs-Occasional Drinker
2.292100E-02
Daily Drinker-vs-Social Drinker
3.703600E-02
Weekly Drinker-vs-Occasional Drinker
7.205000E-01
Weekly Drinker-vs-Social Drinker
7.795600E-01
Occasional Drinker-vs-Social Drinker
9.599600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.402800E-01
Normal-vs-Grade 2
5.953800E-02
Normal-vs-Grade 3
1.123610E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.319570E-01
Grade 1-vs-Grade 3
5.662000E-02
Grade 1-vs-Grade 4
3.402800E-01
Grade 2-vs-Grade 3
3.808400E-01
Grade 2-vs-Grade 4
5.953800E-02
Grade 3-vs-Grade 4
1.123610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.271400E-01
Normal-vs-NonDiabetic
3.691700E-02
Diabetic-vs-NonDiabetic
1.976020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.565400E-01
Normal-vs-NoPancreatitis
6.744400E-02
Pancreatitis-vs-NoPancreatitis
2.755600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.010450E-01
Normal-vs-N1
9.009600E-02
N0-vs-N1
9.299400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.791240E-01
Normal-vs-TP53-NonMutant
2.487600E-01
TP53-Mutant-vs-TP53-NonMutant
8.746200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
